Associations Between PG-SGA Criteria with All-cause Mortality of Cancer Patients: Evidence from Baseline and Longitudinal Analyses

Yu Min,Tingting Dai,Ge Song,Xuemei Li,Xiaoxia Liu,Zheran Liu,Qian Yang,Rong Jia,Qiwei Yang,Xingchen Peng,Jitao Zhou

DOI: https://doi.org/10.1016/j.nut.2024.112551

IF: 4.893

2024-01-01

Nutrition

Abstract:Background and Objective The prognostic effects of the Patient-Generated Subjective Global Assessment (PG-SGA) criteria on cancer survivors have been observed but require validation in clinical practice. This study aims to evaluate the prognostic effects of baseline and longitudinal changes in PG-SGA scores on all-cause mortality among Chinese cancer patients in a real-world setting. Method Study patients were selected from one representative tertiary hospital in West China. Kaplan-Meier curves and Cox regression analyses were used to estimate the prognostic effect of baseline as well as dynamics changes of PG-SGA scores with the all-cause mortality of cancer patients. Receiver operating characteristic (ROC) and concordance index were used to evaluate the predictive accuracy of PG-SGA criteria. Results There were 1,415 cancer patients included in our study, with a mean age of 46 years old. The Cox regression analysis showed that baseline malnourished status was significantly associated with the survival of cancer patients [≥4 PG-SGA <9: hazard ratio (HR): 1.46, 95% confidence interval (CI): 1.09 – 1.96, p = 0.012; PG-SGA ≥9: HR=1.78, 95%CI: 1.34 – 2.37, p < 0.001]. Cancer patients with longitudinal increased PG-SGA scores (>2 points) were observed to have high risks for mortality (HR = 1.69, 95%CI: 1.04 – 2.74, p = 0.033). Compared with longitudinal changes in PG-SGA scores, the baseline malnourished status showed higher predictive power in identifying the risk subgroup (concordance index: 0.646 vs. 0.586). The sensitive analyses supported the main findings as we determined. Conclusions Our study highlights the prognostic value of baseline and dynamic changes of PG-SGA scores for cancer patients, which can help to improve the outcomes of cancer patients.